These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 15078927)
1. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. Kaufmann DE; Bailey PM; Sidney J; Wagner B; Norris PJ; Johnston MN; Cosimi LA; Addo MM; Lichterfeld M; Altfeld M; Frahm N; Brander C; Sette A; Walker BD; Rosenberg ES J Virol; 2004 May; 78(9):4463-77. PubMed ID: 15078927 [TBL] [Abstract][Full Text] [Related]
2. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles. Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314 [TBL] [Abstract][Full Text] [Related]
4. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response. Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386 [TBL] [Abstract][Full Text] [Related]
5. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination. Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. Addo MM; Yu XG; Rathod A; Cohen D; Eldridge RL; Strick D; Johnston MN; Corcoran C; Wurcel AG; Fitzpatrick CA; Feeney ME; Rodriguez WR; Basgoz N; Draenert R; Stone DR; Brander C; Goulder PJ; Rosenberg ES; Altfeld M; Walker BD J Virol; 2003 Feb; 77(3):2081-92. PubMed ID: 12525643 [TBL] [Abstract][Full Text] [Related]
7. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage. Buggert M; Norström MM; Czarnecki C; Tupin E; Luo M; Gyllensten K; Sönnerborg A; Lundegaard C; Lund O; Nielsen M; Karlsson AC PLoS One; 2012; 7(7):e39874. PubMed ID: 22792193 [TBL] [Abstract][Full Text] [Related]
8. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection. Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003 [TBL] [Abstract][Full Text] [Related]
9. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China. Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032 [TBL] [Abstract][Full Text] [Related]
10. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. Fonseca SG; Coutinho-Silva A; Fonseca LA; Segurado AC; Moraes SL; Rodrigues H; Hammer J; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E AIDS; 2006 Nov; 20(18):2263-73. PubMed ID: 17117012 [TBL] [Abstract][Full Text] [Related]
12. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. Draenert R; Altfeld M; Brander C; Basgoz N; Corcoran C; Wurcel AG; Stone DR; Kalams SA; Trocha A; Addo MM; Goulder PJ; Walker BD J Immunol Methods; 2003 Apr; 275(1-2):19-29. PubMed ID: 12667667 [TBL] [Abstract][Full Text] [Related]
13. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine. Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes. Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660 [TBL] [Abstract][Full Text] [Related]
15. Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides. Almeida RR; Rosa DS; Ribeiro SP; Santana VC; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E PLoS One; 2012; 7(9):e45267. PubMed ID: 23028895 [TBL] [Abstract][Full Text] [Related]
16. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia. Koeppe JR; Campbell TB; Rapaport EL; Wilson CC J Acquir Immune Defic Syndr; 2006 Feb; 41(2):140-8. PubMed ID: 16394844 [TBL] [Abstract][Full Text] [Related]
17. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094 [TBL] [Abstract][Full Text] [Related]
18. Differential Immunodominance Hierarchy of CD8 Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337 [TBL] [Abstract][Full Text] [Related]
19. Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection. Radebe M; Nair K; Chonco F; Bishop K; Wright JK; van der Stok M; Bassett IV; Mncube Z; Altfeld M; Walker BD; Ndung'u T J Infect Dis; 2011 Sep; 204(5):768-76. PubMed ID: 21844303 [TBL] [Abstract][Full Text] [Related]
20. Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection. Ramduth D; Day CL; Thobakgale CF; Mkhwanazi NP; de Pierres C; Reddy S; van der Stok M; Mncube Z; Nair K; Moodley ES; Kaufmann DE; Streeck H; Coovadia HM; Kiepiela P; Goulder PJ; Walker BD PLoS One; 2009; 4(4):e5013. PubMed ID: 19352428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]